Box of 5 Tests

The COVID-19 & Influenza A/B Antigen Combo Test Device is an in vitro immunoassay. The assay is for the direct and qualitative detection of Influenza A and B and SARS-CoV-2 viral nucleoprotein antigens from nasopharyngeal and nasal swab specimens. This test is intended for individuals suspected of respiratory viral infection consistent with Influenza A and Influenza B infection or COVID-19, within the first 7 days of symptom onset.

This test is suitable for use by healthcare professionals and laboratory personnel trained to perform the test.

• Covid 19 Sensitivity – 93.6%; Specificity – 99.7%,
• Influenza A Sensitivity – 94.3%; Specificity – 99.7%,
• Influenza B Sensitivity – 93.3%; Specificity – 99.7%,
• Results in 15 minutes
• Can be used reliably with or without virus symptoms
• Variant and combination sensitive
• Health Canada authorized

For Instructions In French and English Click Here